Search for: "Purdue Pharma Inc."
Results 41 - 60
of 161
Sort by Relevance
|
Sort by Date
11 Sep 2018, 6:00 am
” And the lawsuit, writes the Washington Post, claims that Purdue Pharma L.P. and Purdue Pharma Inc. effectively deluded physicians and patients in Colorado about The post Colorado Sues Purdue Pharma Over Role in Opioid Crisis appeared first on Legal Reader. [read post]
13 Jun 2018, 11:39 pm
The Sackler family has sole ownership of Purdue and holds the majority of the seats on Purdue Pharma Inc. [read post]
22 Mar 2018, 9:30 pm
” The state of Arkansas sued dozens of drug makers and distributors, including Purdue Pharma Inc., over their role in the opioid epidemic. [read post]
16 Feb 2018, 2:06 pm
Inc. [read post]
30 Nov 2017, 8:59 pm
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
26 Sep 2017, 12:46 pm
About a dozen pharmaceutical companies, including Purdue Pharma L.P., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
8 Feb 2017, 3:09 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
16 Jan 2017, 5:44 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
21 Nov 2016, 6:58 am
Purdue Pharma LP et al, 3-13-cv-00571 (NJD November 4, 2016, Order) (Bongiovanni, MJ) [read post]
14 Nov 2016, 9:16 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 Oct 2016, 6:50 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
28 Sep 2016, 8:39 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
18 Sep 2016, 6:03 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
11 Jun 2016, 4:04 am
Purdue Pharma Technologies, Inc. 51. [read post]
27 Mar 2016, 9:59 pm
Noonan -- Last Thursday, the Federal Circuit handed down its non-precedential decision in Purdue Pharma v. [read post]
24 Mar 2016, 10:43 am
Purdue Pharma L.P. [read post]
1 Feb 2016, 10:43 am
The appellant Purdue Pharma was represented by:GREGORY A. [read post]
1 Feb 2016, 8:11 am
By Dennis Crouch Purdue Pharma v. [read post]
31 Jan 2016, 7:57 pm
Laboratories Inc.; Purdue Pharmaceuticals L.P. [read post]
5 Nov 2015, 9:39 pm
Purdue Pharma L.P. et al. v. [read post]
